Tyrrell D J, Sale W S, Slife C W
Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322.
J Biol Chem. 1988 Jun 15;263(17):8464-9.
Liver plasma membranes contain a morphologically distinct protein complex which serves as a substrate for the plasma membrane-associated transglutaminase. The complex, which appears as a two-dimensional sheet, is insoluble in sodium dodecyl sulfate and reducing agents and has been named SITS for sodium dodecyl sulfate-insoluble transglutaminase substrate (Tyrrell, D. J., Sale, W. S., and Slife, C. W. (1988) J. Biol. Chem. 263, 1946-1951). Polyclonal antibodies raised against SITS were used to probe for soluble constituents of the matrix. Immunoblots showed that proteins of 230, 35, and 32 kDa reacted with the anti-SITS antiserum when the soluble fraction from a liver homogenate was examined. The 230-kDa protein was identified as fibronectin after observing cross-reactivity of anti-SITS antiserum with authentic fibronectin and cross-reactivity of anti-fibronectin antiserum with the 230-kDa cytosolic protein and purified SITS. Preincubating anti-SITS antiserum with purified fibronectin decreased immunostaining of the 230-kDa cytosolic protein and authentic fibronectin. Immunoblots of the plasma membrane fraction using anti-SITS and anti-fibronectin antisera showed that both antisera reacted with proteins at the top of the stacking gel (SITS) and of 230 kDa. In addition, the anti-SITS antiserum reacted with proteins of 85, 35, and 32 kDa. Immunofluorescence microscopy revealed that the anti-SITS and anti-fibronectin antisera both react with isolated SITS and with the same filamentous structures associated with intact plasma membranes. These studies show that fibronectin is a component of the plasma membrane matrix, SITS. This finding is consistent with the proposed role of this matrix which is to mediate cell-cell adhesion between hepatocytes in the tissue.
肝细胞膜含有一种形态独特的蛋白质复合物,它是与细胞膜相关的转谷氨酰胺酶的底物。该复合物呈二维片状,不溶于十二烷基硫酸钠和还原剂,因其不溶于十二烷基硫酸钠,故被命名为SITS(十二烷基硫酸钠不溶性转谷氨酰胺酶底物)(泰勒尔,D.J.,萨尔,W.S.,和斯利夫,C.W.(1988年)《生物化学杂志》263卷,1946 - 1951页)。用针对SITS产生的多克隆抗体来探测该基质的可溶性成分。免疫印迹显示,当检测肝匀浆的可溶性部分时,230 kDa、35 kDa和32 kDa的蛋白质与抗SITS抗血清发生反应。在用抗SITS抗血清与纯纤连蛋白观察到交叉反应,以及抗纤连蛋白抗血清与230 kDa胞质蛋白和纯化的SITS观察到交叉反应后,230 kDa的蛋白质被鉴定为纤连蛋白。用纯化的纤连蛋白预孵育抗SITS抗血清会降低230 kDa胞质蛋白和纯纤连蛋白的免疫染色。使用抗SITS和抗纤连蛋白抗血清对细胞膜部分进行免疫印迹显示,两种抗血清都与堆积胶顶部的蛋白质(SITS)以及230 kDa的蛋白质发生反应。此外,抗SITS抗血清还与85 kDa、35 kDa和32 kDa的蛋白质发生反应。免疫荧光显微镜检查显示,抗SITS和抗纤连蛋白抗血清都与分离的SITS以及与完整细胞膜相关的相同丝状结构发生反应。这些研究表明纤连蛋白是细胞膜基质SITS的一个组成部分。这一发现与该基质的推测作用一致,即介导组织中肝细胞之间的细胞 - 细胞黏附。